Winnie Liu

Winnie Liu

Auto-generated profile, based on publicly available information

Winnie Liu

Johns Hopkins University School of Medicine, Baltimore MD 21205, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
JHJoshua aiden Hill
Joshua aiden Hill
EKErika S. Kiem
Erika S. Kiem
ABAtif Bhatti
Atif Bhatti
WLWinnie Liu
Winnie Liu
JKJacob Keane-Candib
Jacob Keane-Candib
SJShaun W. Jackson
Shaun W. Jackson
Antibodies against foreign human leukocyte antigen (HLA) molecules are barriers to successful organ transplantation. B cell-depleting treatments are used to reduce anti-HLA antibodies but have limited efficacy. We hypothesized that the primary source for anti-HLA antibodies is long-lived plasma cells, which are ineffectively targeted by B cell depletion. To study this, we screened for anti-HLA antibodies in a prospectively enrolled cohort of 49 patients who received chimeric antigen receptor T-cell therapy (CARTx), targeting naïve and memory B cells (CD19-targeted, n = 21) or plasma cells (BCMA-targeted, n = 28) for hematologic malignancies. Longitudinal samples were collected before and up to 1 year after CARTx. All individuals were in sustained remission. We identified 4 participants with anti-HLA antibodies before CD19-CARTx. Despite B cell depletion, anti-HLA antibodies and calculated panel reactive antibody scores were stable for 1 year after CD19-CARTx. Only 1 BCMA-CARTx recipient had pre-CARTx low-level anti-HLA antibodies, with no follow-up samples available. These data implicate CD19neg long-lived plasma cells as an important source for anti-HLA antibodies, a model supported by infrequent HLA sensitization in BCMA-CARTx subjects receiving previous plasma cell-targeted therapies. Thus, plasma cell-targeted therapies may be more effective against HLA antibodies, thereby enabling improved access to organ transplantation and rejection management.

7 August 2025 in Perspectives on Medical Education
Verified
Journal Article
Open access
PDF file
WLWinnie L. Liu
Winnie L. Liu
MCMargaret S Chisolm
Margaret S Chisolm
Medical schools are increasingly incorporating the arts and humanities into their curricula, often emphasizing their benefits in enhancing students’ clinical skills. However, the potential for these curricula to foster flourishing is equally, if not more, crucial. Although limited in scope, current literature suggests that art museum-based medical education, particularly as Visual Thinking Strategies, may support flourishing among medical learners—although more research is needed to assess the impact of these methods and their mechanisms on learners. In this article, the authors explore how integrating art museum-based programs into medical school curricula can enhance all five domains of the VanderWeele model of human flourishing: physical and mental health, happiness and life satisfaction, meaning and purpose, character and virtue, and close social relationships.

24 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JKJin Kook Kang
Jin Kook Kang
SFShi Nan Feng
Shi Nan Feng
WLWinnie L. Liu
Winnie L. Liu
JKJiah Kim
Jiah Kim
AKAndrew Kalra
Andrew Kalra
Sung-Min ChoSung-Min Cho
Sung-Min Cho
Objective: We aimed to characterize the impact of body mass index (BMI) on stroke in patients receiving extracorporeal cardiopulmonary resuscitation (ECPR). Methods: We queried the Extracorporeal Life Support Organization registry for patients receiving ECPR (2020–2024). Patients were categorized into five BMI groups: underweight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25–29.9 kg/m2), class 1 obesity (30–34.9 kg/m2), and class 2 obesity or above (≥35 kg/m2). A generalized additive model (GAM) analysis was used to identify the BMI range with the greatest stroke risk. Multivariable regression was used to compare odds of stroke between standard BMI groups and normal weight. Propensity score matching was used to compare stroke and mortality between normal weight and the BMI group with the highest predicted stroke risk. Results: Of 6390 patients (median age = 57.5, 68.6% male), 470 (7.4%) had a stroke during ECMO support (4.5% ischemic; 3.4% hemorrhagic). A total of 9.6% (n = 131) of class 1 obesity patients experienced stroke compared with 6.6% (n = 111) of normal weight, 6.9% (n = 79) of class 2 obesity or above, 6.9% (n = 143) of overweight, and 5.4% (n = 6) of underweight patients (p = 0.01). The GAM analysis showed a highest predicted stroke risk for class 1 obesity patients (n = 1366), which was confirmed by multivariable regression (adjusted odds ratio (aOR) = 1.63, 95%CI = 1.01–2.62, p = 0.045). After propensity matching (n = 357 each), class 1 obesity was associated with ischemic (aOR = 2.01, 95%CI = 1.02–4.08, p = 0.047) but not hemorrhagic stroke. Odds of hospital mortality were higher in both class 1 and 2 obesity patients compared with normal weight. Conclusions: Class 1 obesity was associated with increased odds of ischemic but not hemorrhagic stroke compared with normal weight patients.

22 January 2026 in AJO International
Verified
Journal Article
Open access
SWSheila West
Sheila West
ISIan J. Saldanha
Ian J. Saldanha
FWFasika Woreta
Fasika Woreta
CAChristina Ambrosino
Christina Ambrosino
JMJay Maturi
Jay Maturi
SMSilvio P. Mariotti
Silvio P. Mariotti
The World Health Organization (WHO) has specified a global target for "effective cataract surgery coverage" for monitoring progress towards tincreasing eye care quality across populations. The WHO is committed to providing evidence-based guidance for components of cataract surgerythat could lead to better outcomes. The first step is a scoping review of from existing guidelines, including the evidence base and gaps in the evidence for those guidelines. We developed a conceptual framework for the scoping review that compartmentalized stages of cataract surgery into pre-operative, operative, and postoperative phases and identified potential outcome indicators. A search strategy was developed. In 2024, we used a multipronged approach to identify existing guidelines that support cataract surgery programs, reviewed known publicly available cataract surgery quality improvement programs, searched the Trip Medical Database, and reviewed materials sent to us directly from WHO. We noted the evidence-base of the guidelines. Of the 156 sources, 34 had guidelines. Seven guidelines were cited by multiple sources with good evidence; these include use of pre-operative povidone-iodine, a "time-out" checklist, intracameral antibiotics, and phacoemulsification. Some guidelines were inconsistent and require harmonization, such as the necessity for pre-operative medical visits and laboratory testing, and benchmarks for outcome assessment. Gaps in evidence were also found, such as details on what constitutes "accurate" biometry. While these results are a reasonable starting point for WHO to begin the development of guidance for effective cataract surgery, there is an urgent need to generate data that will fill identified gaps in evidence and to harmonize inconsistencies going forward.

25 May 2025 in Clinical Neurophysiology
Verified
Journal Article
Closed access
Mingfeng CaoMingfeng Cao
Mingfeng Cao
SKShivalika Khanduja
Shivalika Khanduja
WLWinnie Liu
Winnie Liu
SFShi Nan Feng
Shi Nan Feng
JKJin Kook Kang
Jin Kook Kang
Sung-Min ChoSung-Min Cho
Sung-Min Cho